Literature DB >> 16505606

Inhibition of the allergic response by regulatory T cells.

Philippe Stock1, Rosemarie H DeKruyff, Dale T Umetsu.   

Abstract

PURPOSE OF REVIEW: Allergic diseases are caused by the overdevelopment of T-helper type 2 biased immune responses in susceptible individuals. A number of recent studies indicate that regulatory T cells play an important role in controlling such T-helper type 2 biased responses not only in animal models, but in humans as well, and these will be reviewed in this article. RECENT
FINDINGS: A family of regulatory cells appears to be involved in regulating allergies. Both naturally occurring CD4CD25 regulatory T cells and inducible forms of antigen-specific regulatory T cells, both expressing the transcription factor foxp3, have been shown to inhibit the inappropriate immune responses involved in allergic diseases. Impaired expansion of natural or adaptive regulatory T cells is hypothesized to lead to the development of allergy, and treatment to induce allergen-specific regulatory T cells could provide curative therapies for allergy and asthma.
SUMMARY: Allergen-specific regulatory T cells play an important role in controlling the development of allergy and asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505606     DOI: 10.1097/01.all.0000200502.69672.44

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  9 in total

1.  Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation.

Authors:  Je-Min Choi; Jae-Hun Shin; Myung-Hyun Sohn; Martha J Harding; Jong-Hyun Park; Zuzana Tobiasova; Da-Young Kim; Stephen E Maher; Wook-Jin Chae; Sung-Ho Park; Chun-Geun Lee; Sang-Kyou Lee; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

2.  Asthma and gender impact accumulation of T cell subtypes.

Authors:  Matthew J Loza; Susan Foster; Eugene R Bleecker; Stephen P Peters; Raymond B Penn
Journal:  Respir Res       Date:  2010-07-28

3.  Immune response to Streptococcus pneumoniae in asthma patients: comparison between stable situation and exacerbation.

Authors:  C Otero; R D Paz; N Galassi; L Bezrodnik; M R Finiasz; S Fink
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

4.  Role of immune tolerance in BALB/c mice with anaphylactic shock after Echinococcus granulosus infection.

Authors:  Qin Zhang; Jian-Rong Ye; Hai-Mei Ma; Jian-Jiang Wu; Tao Jiang; Hong Zheng
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  Interleukin-4 suppresses the cytotoxic potential of in vitro generated, adaptive regulatory CD4 T cells by down-regulation of granzyme B.

Authors:  Kai Bratke; Hilke Goettsching; Michael Kuepper; Simone Geyer; Werner Luttmann; J Christian Virchow
Journal:  Immunology       Date:  2008-12-23       Impact factor: 7.397

6.  Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4.

Authors:  Karine Botturi; Yannick Lacoeuille; Arnaud Cavaillès; Daniel Vervloet; Antoine Magnan
Journal:  Respir Res       Date:  2011-02-28

7.  Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells.

Authors:  Jingyi Hong; Xiaojun Xiao; Qichan Gao; Shanshan Li; Bei Jiang; Xizhuo Sun; Pixin Ran; Pingchang Yang
Journal:  Int J Nanomedicine       Date:  2019-08-30

Review 8.  New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.

Authors:  Miguel Angel Galván Morales; Josaphat Miguel Montero-Vargas; Juan Carlos Vizuet-de-Rueda; Luis M Teran
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

9.  Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma.

Authors:  Eric R Secor; William F Carson; Anurag Singh; Mellisa Pensa; Linda A Guernsey; Craig M Schramm; Roger S Thrall
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.